Multifocal Motor Neuropathy (MMN)
Neurology·MeSH: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Prevalence
0.5 / 100K
4 drugs in development·1 company·5 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Phase 2(1)
| Drug | Company |
|---|---|
| argx-117 | ARGENX SE (ARGX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Multifocal Motor Neuropathy (MMN)?
BioSniper tracks 4 drugs in development for Multifocal Motor Neuropathy (MMN) across 1 company.
How many clinical trials target Multifocal Motor Neuropathy (MMN)?
There are 5 clinical trials targeting Multifocal Motor Neuropathy (MMN) tracked by BioSniper.
What is the prevalence of Multifocal Motor Neuropathy (MMN)?
The estimated prevalence of Multifocal Motor Neuropathy (MMN) is approximately 0.5 per 100,000 population.
Deep-dive into Multifocal Motor Neuropathy (MMN)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis